Pfizer Introduces Further Voluntary Recall of EpiPen 0.3 mg in Japan

Pfizer Japan said on April 3 that it will expand the range of voluntary recall of the emergency anaphylaxis treatment EpiPen Injection 0.3 mg (epinephrine), which the company initiated on March 13, adding another lot of the product. Products with...read more